February 3, 2014

The Generic Pharmaceutical Association on Monday identified its key priorities for 2014 — guarding against confusion a proposed labeling change would cause; gaining access to biosimilar generics; and heralding the cost savings generated by generic utilization.

February 3, 2014

Script Relief launched a new and improved HelpRx website that, according to the company, aims to provide a user-friendly experience and additional resources to people searching for prescription drug discounts, as well as information about medications.

January 31, 2014

The imminent entry of several companies — including big pharma, small biotech and generic participants — into the global biosimilars space will propel the market toward exponential growth. The market is expected to soar from $1.2 billion in 2013 to $24 billion in 2019, reported Frost & Sullivan in research released earlier this week.

January 31, 2014

The Biotechnology Industry Organization and the Indiana Health Industry Forum commended the Indiana Senate for passing legislation designed to create a pathway for the substitution of interchangeable biologic medicines.

January 16, 2014

The U.S. House of Representatives on Wednesday voted to restore $85 million in Food and Drug Administration sequestered user fees.

January 9, 2014

Bi-Lo and Winn-Dixie will cover initial prescription costs for customers who have enrolled in the health insurance marketplaces, but don't yet have their identification cards, the chains said.

January 9, 2014

Vulnerable patients, including seniors and cancer patients, suffer from lack of access to needed painkillers as efforts to combat diversion and misuse of controlled substances often result in drugs not getting into the hands of those who need them, according to a new pharmacist survey by the National Community Pharmacists Association.

January 8, 2014

Aetna has announced that Walmart and Sam’s Club pharmacies have been added to the preferred pharmacy network of the Aetna CVS/pharmacy Prescription Drug Plan as of Jan. 1.

December 4, 2013

Cardinal Health Foundation recently awarded more than $350,000 in grant funding to 29 nonprofit organizations that are dedicated to the fight against prescription drug abuse, the organization announced Wednesday.

November 21, 2013

The National Association of Chain Drug Stores has announced that in lead-up to a hearing of the Subcommittee on Health of the U.S. House of Representatives Committee on Energy and Commerce, it has submitted a statement emphasizing the important collaborative role that pharmacy plays in helping to ensure that prescription medications are used appropriately and that local communities are safe.

November 18, 2013

The global market for biosimilars is expected to be worth nearly $2 billion before the end of the decade, according to a new study.

November 13, 2013

Sohm on Tuesday announced the U.S. launch of its umbrella brand SohMed, positioning the company in the generic over-the-counter medicines segment for indications of pain, fever, cold, antacid and alertness.

November 5, 2013

A recently released clinical trial has found that patients taking a biotech drug for arthritis and those taking a biosimilar version had similar responses to both treatments.

October 29, 2013

In what is emerging as the latest battle over follow-on biologics, a new argument has emerged about what to call them, and supporters of biotechnology companies are the latest to take a shot.

October 25, 2013

Three pharmacy groups are petitioning the World Health Organization to uphold common generic names for biosimilars and their branded reference products.

October 25, 2013

In recognition of National Prescription Drug Take Back Day being held Oct. 26, CVS/pharmacy has launched the CVS/pharmacy Medication Disposal for Safer Communities Program.

October 25, 2013

The Food and Drug Administration plans to recommend stronger regulations for a commonly used opioid painkiller.

October 22, 2013

A top executive of generic drug maker Hospira spoke in favor of giving biosimilar drugs the same generic names as the branded biologics they're based on.

October 17, 2013

As knock-off versions of biotech drugs get closer to reality in the United States, one issue that has emerged has centered on what to call them.

October 16, 2013

Medicare beneficiaries' use of medications — both effective and risky — varies widely across different regions of the United States, according to a new report.

October 14, 2013

The governor of California has vetoed a bill that critics said would have limited patients' access to knock-off versions of biotech drugs.

October 10, 2013

When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.

October 7, 2013

A trade group of generic drug makers is hoping that California's governor vetoes a bill that it says would restrict patients' access to biosimilars.

October 1, 2013

The message in October is "Know Your Pharmacist, Know Your Medicine" as the American Pharmacists Association launches its annual American Pharmacists Month.